166 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

BioNTech Acquisitions

BioNTech has acquired 8 companies and its latest acquisition was CureVac N.V. on Jun 2025

Unlock 5 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
CureVac N.V.

Jun 2025

Source »
$1.3B
CureVac is a Germany-based biopharmaceutical company that researches and develops mRNA therapies for the treatment of cancer and infectious diseases.
Biotheus, Inc.

Nov 2024

Source »
$800M
Biotheus is a Guangdong-based biotechnology company that develops and commercializes therapies for the treatment of cancer and autoimmune diseases.
InstaDeep Ltd.

Jan 2023

Source »
$440.1M
InstaDeep is an England-based AI company that develops software products offering solutions such as protein design and 3D packing for various industries.
PhagoMed Biopharma GmbH

Nov 2021

Source »
undisclosed
PhagoMed is an Austria-based biotechnology company that develops and commercializes therapies for the treatment of bacterial infections.

-

Tumor Neoantigen T Cell Receptor R&D Platform Clinical Manufacturing Facility Business in Gaithersburg, Maryland, Kite

Jul 2021

Source »
undisclosed
-

Frequently Asked Questions about BioNTech

  1. What companies did BioNTech acquire?

    Companies acquired by BioNTech include CureVac, Biotheus and InstaDeep

  2. How many acquisitions does BioNTech have?

    BioNTech has acquired 8 companies including CureVac, Biotheus and InstaDeep.

  1. How many acquisitions did BioNTech make in 2025?

    In 2025 BioNTech acquired 1 companies including CureVac.